LGYV
LEGACY VENTURES INTERNATIONAL INC.Company Information
- Company Name
- LEGACY VENTURES INTERNATIONAL INC.
- CIK
- CIK0001616788
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- LGYV: OTC
- Fiscal Year End
- June 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- LGYV
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2025-05-08
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- 0.00%
Balance Sheet
Values in millions ($)| Line item | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Prepaid Expense Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Cash | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Due To Affiliate Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Other Liabilities Current | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Retained Earnings Accumulated Deficit | -7 | -7 | -7 | -7 | -7 | -7 | -7 | -6 | -6 | -6 | -6 | -7 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | - | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 50 | 50 | 50 | 50 | 50 | 50 | 50 | - | 50 | 50 | 50 | 0 | ||||||
| Shares Outstanding | 50 | 50 | 50 | 50 | 50 | 50 | 50 | - | 50 | 50 | 50 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLEGACY VENTURES INTERNATIONAL INC. (LGYV) — SEC Financial Statements & Analysis
LEGACY VENTURES INTERNATIONAL INC. (LGYV) is a surgical & medical instruments & apparatus company, incorporated in NV. LEGACY VENTURES INTERNATIONAL INC. trades on OTC as: LGYV. LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s most recent SEC filing is a Form 10-Q for the period ended 2024-12-31, filed with the SEC on 2025-05-08. Based on that filing, LEGACY VENTURES INTERNATIONAL INC. carries a market cap of $100.63M, a P/E ratio of -1106.23x, a P/B ratio of -555.78x, an enterprise value of $100.63M, and an EV/EBITDA multiple of -1106.22x. On profitability, it posts a Return on Equity (ROE) of 67.10%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 72.34% year-over-year and EPS growth of 72.34% year-over-year. On the balance sheet, it maintains an interest coverage ratio of -4.10x, free cash flow of $-90.25K (TTM), and net debt of $-983. Figures sourced from SEC EDGAR.
- Market Cap
- $100.63M
- P/E TTM
- -1106.23x
- EPS TTM
- $-0.00
- P/B TTM
- -555.78x
- ROE TTM
- 67.10%
- Free Cash Flow TTM
- $-90.25K
Data as of 2024-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LEGACY VENTURES INTERNATIONAL INC. in?
LEGACY VENTURES INTERNATIONAL INC. (LGYV) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does LGYV trade on?
LEGACY VENTURES INTERNATIONAL INC. (LGYV) trades on the OTC.
Where is LEGACY VENTURES INTERNATIONAL INC. incorporated?
LEGACY VENTURES INTERNATIONAL INC. is incorporated in NV.
When was LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s most recent SEC filing?
LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s most recent SEC filing is a Form 10-Q for the period ended 2024-12-31, filed with the SEC on 2025-05-08.
What is LGYV's market cap?
LEGACY VENTURES INTERNATIONAL INC. (LGYV) has a market capitalization of $100.63M as of 2024-12-31.
What is LGYV's EPS (earnings per share)?
LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s trailing twelve month EPS is $-0.00 as of 2024-12-31.
What is LGYV's ROE (return on equity)?
LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s trailing twelve month Return on Equity (ROE) is 67.10% as of 2024-12-31.
What is LGYV's EV/EBITDA?
LEGACY VENTURES INTERNATIONAL INC. (LGYV)'s trailing twelve month EV/EBITDA is -1106.22x as of 2024-12-31.